Hong Kong Widens Health Inspections After Melamine In New Product
This article was originally published in PharmAsia News
Hong Kong officials have ordered broader inspection of products from mainland China after the chemical melamine was discovered in yet another product. Hong Kong's regional secretary for food and health said melamine possibly added to chicken feed had led to traces of the chemical in eggs from the mainland, so the automatic inspections would include mainland meat in addition to other food and drug products. Premier Wen Jiabao has acknowledged the Chinese government failed to use the regulatory authority of the State FDA to guard against contaminated products. In addition to companies involved, the melamine scare was the problem of the government, "especially in the field of regulation and management," he said. (Click here for more
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.